All members of the board of directors of COSMO Pharmaceuticals N.V., a public company organized and existing under the laws of the Netherlands, having its corporate seat in Amsterdam, the Netherlands, with office address at Riverside II, Sir John Rogerson’s Quay, Dublin 2, Ireland and registered with the Trade Register of the Dutch Chamber of Commerce under number 65617738 (the “Acquiring Company”); and all members of the board of directors of COSMOAll members of the board of directors of COSMO Pharmaceuticals N.V., a public company organized and existing under the laws of the Netherlands, having its corporate seat in Amsterdam, the Netherlands, with office address at Riverside II, Sir John Rogerson’s Quay, Dublin 2, Ireland and registered with the Trade Register of the Dutch Chamber of Commerce under number 65617738 (the “Acquiring Company”); and all members of the board of directors of COSMOAll members of the board of directors of COSMO Pharmaceuticals N.V., a public company organized and existing under the laws of the Netherlands, having its corporate seat in Amsterdam, the Netherlands, with office address at Riverside II, Sir John Rogerson’s Quay, Dublin 2, Ireland and registered with the Trade Register of the Dutch Chamber of Commerce under number 65617738 (the “Acquiring Company”); and all members of the board of directors of COSMOAll members of the board of directors of COSMO Pharmaceuticals N.V., a public company organized and existing under the laws of the Netherlands, having its corporate seat in Amsterdam, the Netherlands, with office address at Riverside II, Sir John Rogerson’s Quay, Dublin 2, Ireland and registered with the Trade Register of the Dutch Chamber of Commerce under number 65617738 (the “Acquiring Company”); and all members of the board of directors of COSMOAll members of the board of directors of COSMO Pharmaceuticals N.V., a public company organized and existing under the laws of the Netherlands, having its corporate seat in Amsterdam, the Netherlands, with office address at Riverside II, Sir John Rogerson’s Quay, Dublin 2, Ireland and registered with the Trade Register of the Dutch Chamber of Commerce under number 65617738 (the “Acquiring Company”); and all members of the board of directors of COSMOAll members of the board of directors of COSMO Pharmaceuticals N.V., a public company organized and existing under the laws of the Netherlands, having its corporate seat in Amsterdam, the Netherlands, with office address at Riverside II, Sir John Rogerson’s Quay, Dublin 2, Ireland and registered with the Trade Register of the Dutch Chamber of Commerce under number 65617738 (the “Acquiring Company”); and all members of the board of directors of COSMOAll members of the board of directors of COSMO Pharmaceuticals N.V., a public company organized and existing under the laws of the Netherlands, having its corporate seat in Amsterdam, the Netherlands, with office address at Riverside II, Sir John Rogerson’s Quay, Dublin 2, Ireland and registered with the Trade Register of the Dutch Chamber of Commerce under number 65617738 (the “Acquiring Company”); and all members of the board of directors of COSMOAll members of the board of directors of COSMO Pharmaceuticals N.V., a public company organized and existing under the laws of the Netherlands, having its corporate seat in Amsterdam, the Netherlands, with office address at Riverside II, Sir John Rogerson’s Quay, Dublin 2, Ireland and registered with the Trade Register of the Dutch Chamber of Commerce under number 65617738 (the “Acquiring Company”); and all members of the board of directors of COSMOAll members of the board of directors of COSMO Pharmaceuticals N.V., a public company organized and existing under the laws of the Netherlands, having its corporate seat in Amsterdam, the Netherlands, with office address at Riverside II, Sir John Rogerson’s Quay, Dublin 2, Ireland and registered with the Trade Register of the Dutch Chamber of Commerce under number 65617738 (the “Acquiring Company”); and all members of the board of directors of COSMOAll members of the board of directors of COSMO Pharmaceuticals N.V., a public company organized and existing under the laws of the Netherlands, having its corporate seat in Amsterdam, the Netherlands, with office address at Riverside II, Sir John Rogerson’s Quay, Dublin 2, Ireland and registered with the Trade Register of the Dutch Chamber of Commerce under number 65617738 (the “Acquiring Company”); and all members of the board of directors of COSMO